Chemical Component Summary

NameTAZOBACTAM
Identifiers(2S,3S,5S)-3-methyl-4,4,7-trioxo-3-(1,2,3-triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
FormulaC10 H12 N4 O5 S
Molecular Weight300.29
TypeNON-POLYMER
Isomeric SMILESC[C@]1(Cn2ccnn2)[C@@H](N2[C@H](CC2=O)S1(=O)=O)C(O)=O
InChIInChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8-,10-/m0/s1
InChIKeyLPQZKKCYTLCDGQ-NRPADANISA-N

Chemical Details

Formal Charge0
Atom Count32
Chiral Atom Count3
Chiral AtomsC2, C3, C5
Bond Count34
Aromatic Bond Count5
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB01606 Different stereochemistry
NameTazobactam
Groupsapproved
DescriptionTazobactam is a antibacterial penicillin derivative which inhibits the action of bacterial beta-lactamases.
Synonyms
  • CL-298741
  • Tazobactam
  • YTR-830H
SaltsTazobactam sodium
Brand Names
  • Jamp-pip/taz
  • Mylan-piperacillin and Tazobactam for Injection
  • Piperacillin / Tazobactam Powder for In
Affected OrganismEnteric bacteria and other eubacteria
IndicationUsed in combination with piperacillin to broaden the spectrum of piperacillin antibacterial action.
PharmacologyTazobactam is a compound which inhibits the action of bacterial beta-lactamases. It is added to the extended spectrum beta-lactam antibiotic piperacillin.
Mechanism of actionTazobactam broadens the spectrum of piperacillin by making it effective against organisms that express beta-lactamase and would normally degrade piperacillin.
Route of administration
  • Intravenous
  • Intravenous; Parenteral
Categories
  • Amides
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antibacterials for Systemic Use
  • Antiinfectives for Systemic Use
ATC-CodeJ01CG02
CAS number89786-04-9
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682